Outcome of Plasma Exchange Therapy in Thrombotic Microangiopathy After Renal Transplantation (Q44596912)

4 December 2017

title

Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation (English)

1 reference

4 December 2017

Outcome of Plasma Exchange Therapy in Thrombotic Microangiopathy After Renal Transplantation (English)

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

14 March 2024

author name string

Vanji Karthikeyan

1

1 reference

4 December 2017

Raviprasenna Parasuraman

2

1 reference

4 December 2017

Veena Shah

3

1 reference

4 December 2017

Edgard Vera

4

1 reference

4 December 2017

K. K. Venkat

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510703

14 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://doi.org/10.1046/j.1600-6143.2003.00222.x

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14510703

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1600-6143.2003.00222.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1600-6143.2003.00222.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

https://onlinelibrary.wiley.com/doi/full-xml/10.1046/j.1600-6143.2003.00222.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

https://api.elsevier.com/content/article/PII:S1600613522076420?httpAccept=text/xml

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

https://api.elsevier.com/content/article/PII:S1600613522076420?httpAccept=text/plain

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

American Journal of Transplantation

14 March 2024

published in

1 reference

4 December 2017

volume

3

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1289-1294

1 reference

Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

Thrombotic microangiopathy early after kidney transplantation: hemolytic uremic syndrome or vascular rejection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

Effect of Cyclosporin A on prostacyclin synthesis by vascular tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

Renal vascular and thrombotic effects of cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

THROMBOTIC THROMBOCYTOPENIC PURPURA

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

Mycophenolate mofetil in cyclosporin-associated thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

Severe vital depression as the presenting feature of cyclosporin-A-associated thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

Hemolytic uremic syndrome in renal allografted patients treated with cyclosporin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

A hemolytic-uremic syndrome with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2003.00222.X

Cyclosporine and tacrolimus-associated thrombotic microangiopathy

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Thrombotic microangiopathies

14 March 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

FK506-associated thrombotic microangiopathy: report of two cases and review of the literature

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation.

14 March 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Prognostic factors of hemolytic uremic syndrome in renal allografts

14 March 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

14 March 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy

14 March 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Thrombotic thrombocytopenic purpura associated with ticlopidine

14 March 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Thrombotic thrombocytopenic purpura, cholangiocarcinoma, and oral contraceptives

14 March 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis

14 March 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Cyclosporine inhibits prostacyclin production by cultured human endothelial cells

14 March 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

14 March 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

14 March 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

Haemolytic uraemic syndrome in a renal transplant recipient during OKT3 therapy

14 March 2024

42

1 reference

https://api.crossref.org/works/10.1046/J.1600-6143.2003.00222.X

14 March 2024

Identifiers

1 reference

4 December 2017

1 reference